Anirvan Ghosh, Chief Executive Officer at Unity Biotechnology, Inc. (UBX), sold 604 shares at $1.53 ($924) on 2024-08-02, disclosed to the SEC on 2024-08-06.
Scheduled sale ($924) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| UBX | SELL | 2024-11-06 | $557 | — | Filing → |
| UBX | SELL | 2024-06-26 | $2K | — | Filing → |
| UBX | SELL | 2024-05-03 | $935 | — | Filing → |